Perrigo Sued in Securities Class Action Over Infant-Formula Disclosures as Law Firms Recruit Lead Plaintiffs

Overview

• The complaint, filed November 17, 2025 in the Southern District of New York, names Perrigo Company plc and certain current and former officers as defendants.
• Plaintiffs allege Perrigo misled investors about the Nestlé‑acquired infant‑formula business, citing underinvestment, costly remediation needs beyond public estimates, manufacturing deficiencies, and overstated earnings and cash flow.
• The filing ties sharp stock declines to a series of disclosures on February 27, 2024, May 7, 2024, August 6, 2025, and November 5, 2025, including reported remediation costs, production issues, and inventory scrap.
• On November 5, 2025, Perrigo announced a strategic review of the infant‑formula unit, a reassessment of a previously planned $240 million investment, and a cut to its fiscal 2025 outlook.
• Multiple firms—including Robbins Geller, Glancy Prongay & Murray, Rosen, Schall, and Lowey Dannenberg—are soliciting investors for lead‑plaintiff roles, with most notices citing a class period of February 27, 2023 to November 4, 2025 and one listing a 2025 start, and no class has been certified.